Polyrizon Ltd.(PLRZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PLRZ Polyrizon Ltd.

Pre-Mkt 12-16 06:15:58 EST

11.82

-0.79

-6.26%

盘前11.40

-0.42-3.55%

05:31 EST

High12.47	Low10.70	Vol185.70K
Open11.89	D1 Closing12.61	Amplitude14.04%
Mkt Cap12.31M	Tradable Cap11.78M	Total Shares1.04M
T/O2.14M	T/O Rate18.63%	Tradable Shares996.80K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":11.82,"timestamp":1765832400000,"preClose":12.61,"halted":0,"volume":185700,"hourTrading":{"tag":"盘前","latestPrice":11.4,"preClose":11.82,"latestTime":"05:31 EST","volume":1,"amount":11.4,"timestamp":1765881060264},"delay":0,"floatShares":996800,"shares":1041700,"eps":0,"marketStatus":"Pre-Mkt","change":-0.79,"latestTime":"12-16 06:15:58 EST","open":11.89,"high":12.47,"low":10.7001,"amount":2144455.2435,"amplitude":0.140357,"askPrice":13.11,"askSize":100,"bidPrice":11.31,"bidSize":20,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765895400000},"marketStatusCode":1,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":11.82,"preHourTrading":{"tag":"盘前","latestPrice":11.4,"preClose":11.82,"latestTime":"05:31 EST","volume":1,"amount":11.4,"timestamp":1765881060264},"postHourTrading":{"tag":"盘后","latestPrice":11.31,"preClose":11.82,"latestTime":"19:59 EST","volume":3254,"amount":37303.1898,"timestamp":1765846783518},"volumeRatio":0.3205504422512161},"requestUrl":"/m/hq/s/PLRZ","defaultTab":"news","newsList":[{"id":"2590161105","title":"Polyrizon Reports Intranasal Naloxone Hydrogel Matches Marketed Product in Rapid Permeation","url":"https://stock-news.laohu8.com/highlight/detail?id=2590161105","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590161105?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:15","pubTimestamp":1765458914,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd., a biotechnology company focused on intranasal products, has announced promising preclinical results for its proprietary intranasal naloxone hydrogel formulation. The research demonstrated that the hydrogel offers significantly enhanced tissue retention compared to a currently marketed intranasal naloxone product, without compromising the rapid drug permeation required for emergency opioid overdose treatment. The results, which include stability, mucoadhesion, and permeability studies, reinforce the potential of Polyrizon's Trap & Target technology to deliver improved performance in real-world scenarios. The company has already completed these studies and announced the findings, positioning the product for further development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL4kvcTj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD","NDAQ","LU2095319765.USD","SG9999014005.SGD","SG9999014013.SGD","PLRZ","BK4588","BK4585","SG9999014039.USD"],"gpt_icon":0},{"id":"2590516916","title":"Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2590516916","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590516916?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:15","pubTimestamp":1765458900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA5KZ4ML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2589335638","title":"BRIEF-Polyrizon Completes FDA Pre-Submission Meeting For PL-14 Allergy Blocker Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2589335638","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589335638?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:56","pubTimestamp":1765202176,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Completes FDA Pre-Submission Meeting For PL-14 Allergy Blocker Nasal SprayDec 8 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON COMPLETES FDA PRE-SUBMISSION MEETING FOR PL-14 ALLERGY BLOCKE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA1RNWVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2589356880","title":"Polyrizon Completes FDA Pre-Submission Meeting for Pl-14 Allergy Blocker Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2589356880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589356880?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:55","pubTimestamp":1765202100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA1RNWVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2589489208","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2589489208","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589489208?lang=en_us&edition=fundamental","pubTime":"2025-12-05 20:55","pubTimestamp":1764939318,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals  shares were 19% lower pre-bell Friday after a 6.1% increase in the previous session.Polyrizon  stock was down 17%, paring Thursday's rally.Domo  shares were 14% lower after the company reported late Thursday lower fiscal Q3 revenue.Parsons  stock was down 14% after a 1.9% gain in the previous session.Argan  shares were 11% lower, a day after the company posted lower fiscal Q3 revenue.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0566484027.USD","BK4139","LU1559883803.SGD","AGX","BK4129","PLRZ","BK4023","QNRX","PSN","LU2065731478.USD","DOMO","BK4187","BK4123"],"gpt_icon":1},{"id":"2589834845","title":"Polyrizon Stock Skyrockets After New Data Shows Naloxone Gel Outperforms Marketed Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2589834845","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589834845?lang=en_us&edition=fundamental","pubTime":"2025-12-05 02:45","pubTimestamp":1764873900,"startTime":"0","endTime":"0","summary":"Polyrizon stock is up on new data showing its naloxone hydrogel formulation has stronger and longer-lasting mucosal retention.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/04/Medical-Research.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/04/Medical-Research.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49217116/polyrizon-stock-skyrockets-after-new-data-shows-naloxone-gel-outperforms-marketed-spray","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49217116/polyrizon-stock-skyrockets-after-new-data-shows-naloxone-gel-outperforms-marketed-spray","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["PLRZ","BK4007","SNES"],"gpt_icon":1},{"id":"2589839550","title":"Crude Oil Gains Over 1%; Kroger Shares Slide After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2589839550","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589839550?lang=en_us&edition=fundamental","pubTime":"2025-12-05 01:15","pubTimestamp":1764868518,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/12/49214331/crude-oil-gains-over-1-kroger-shares-slide-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCRN","BK4585","BK4504","LU2275660780.HKD","LU0130102774.USD","BK4113","BK4588","LU0302445910.USD","BK4094","SAIC","BK4551","BK4561","BK4097","BK4149","BK4559","KR","BK4532","LU0345770308.USD","BK4547","LU0980610538.SGD","BK4539","GCO","BK4543","BK4533","LU0477156953.USD","LU1861558580.USD","PLRZ","LU0312595415.SGD","BK4123","PATH","LU0130517989.USD","LU0345770993.USD","BK4505","BK4604","LU1861559042.SGD","KITT","LU0648001328.SGD","LU1201861249.SGD","BK4196"],"gpt_icon":0},{"id":"2588881188","title":"Polyrizon Achieves Manufacturing Milestone for Nasal Hydrogel Barrier","url":"https://stock-news.laohu8.com/highlight/detail?id=2588881188","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588881188?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:32","pubTimestamp":1764851527,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has announced a significant manufacturing milestone in the development of its PL-14 nasal protection hydrogel, designed to trap airborne allergens and potentially viruses at the mucosal level. The company successfully produced larger-scale batches of PL-14 with the help of a leading CDMO partner, meeting all required specifications for consistency, stability, and quality. These results confirm that PL-14 can be reliably scaled for clinical trial supply and future commercial production. The company stated that these achievements pave the way for clinical trials expected to begin in 2026, but the research results have not yet been presented to the public or at scientific meetings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal adv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL8hSWWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NDAQ","IE00BKPKM429.USD","LU2095319765.USD","IE00BGHQF748.EUR","BK4112","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","PLRZ","LU2210150020.SGD","IE00B3QW5Z07.USD"],"gpt_icon":1},{"id":"2588074609","title":"What Sparked Polyrizon's (PLRZ) 140% After-Hours Stock Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2588074609","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588074609?lang=en_us&edition=fundamental","pubTime":"2025-12-04 10:52","pubTimestamp":1764816720,"startTime":"0","endTime":"0","summary":"Polyrizon surged in nearly 140% after-hours trading following preclinical data showing its naloxone hydrogel outperforms a marketed spray and a key manufacturing milestone.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/03/Nasal-Spray--Female-Hand-Spraying-Nasal-.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/03/Nasal-Spray--Female-Hand-Spraying-Nasal-.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/12/49200923/what-sparked-polyrizons-plrz-140-after-hours-stock-surge","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/12/49200923/what-sparked-polyrizons-plrz-140-after-hours-stock-surge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["PLRZ"],"gpt_icon":1},{"id":"2588316042","title":"BRIEF-Polyrizon Reports Positive Mucoadhesion Results For Intranasal Naloxone Hydrogel","url":"https://stock-news.laohu8.com/highlight/detail?id=2588316042","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588316042?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:29","pubTimestamp":1764772155,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Reports Positive Mucoadhesion Results For Intranasal Naloxone Hydrogel Dec 3 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON REPORTS POSITIVE MUCOADHESION RESULTS FOR INTRANASAL NALOXONE HY","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X90SD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2588204235","title":"Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2588204235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588204235?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:28","pubTimestamp":1764772119,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X90SD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2588399042","title":"Polyrizon Reports Superior Mucoadhesion for Intranasal Naloxone Hydrogel in Preclinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2588399042","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588399042?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:28","pubTimestamp":1764772088,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has announced new preclinical data demonstrating that its proprietary intranasal naloxone hydrogel exhibits significantly greater mucoadhesion compared to an existing marketed intranasal naloxone spray. The study, conducted using an ex-vivo rabbit nasal mucosa model, found that the hydrogel formulation maintained higher levels of a fluorescence marker after repeated washing, indicating stronger and more durable retention on the nasal tissue. These results, which have already been presented, suggest that Polyrizon's Trap and Target (T&T) hydrogel technology may enhance bioavailability and reliability for opioid overdose reversal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL9YKLJH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","LU0314104364.USD","IE00BKPKM429.USD","BK4112","LU2210149790.SGD","BK4588","PLRZ","LU2210150020.SGD","NDAQ","IE00B64PRP62.GBP","BK4585","IE00B3QW5Z07.USD"],"gpt_icon":1},{"id":"2588063629","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2588063629","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588063629?lang=en_us&edition=fundamental","pubTime":"2025-12-03 03:15","pubTimestamp":1764702931,"startTime":"0","endTime":"0","summary":"Polyrizon , a biotechnology company developing intranasal products, reported Tuesday the \"successful\" completion of a major manufacturing upscaling milestone for its nasal-spray product platform.Shares surged 140% as intraday trading volume catapulted to over 124.9 million from a daily average of about 181,000.Eventbrite  said it has agreed to be acquired by Bending Spoons in an all-cash transaction valued at about $500 million.Shares soared 78% as intraday trading volume surged to over 25.9 million from a daily average of roughly 557,000.Credo Technology  shares jumped 13% amid heavy trading after the firm reported overnight higher fiscal Q2 adjusted earnings and revenue.Trading volume climbed to more than 13.2 million from a daily average of about 6.29 million.Price: 7.38, Change: +4.22, Percent Change: +133.54","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EB","LU1861215975.USD","LU0082616367.USD","IE0009354923.USD","LU0053671581.USD","BK4588","BK4077","PLRZ","LU2290526834.HKD","BK4108","BK4141","LU1861220033.SGD","LU2360107168.USD","BK4585","LU0719512351.SGD"],"gpt_icon":1},{"id":"2588050489","title":"Gold Down Over 1%; Signet Shares Fall After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2588050489","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588050489?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:29","pubTimestamp":1764696559,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/12/49166700/gold-down-over-1-signet-shares-fall-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087625088.SGD","LU2286300806.USD","LU0719512351.SGD","LU0154245756.USD","PLRZ","LU1861215975.USD","JANX","LU0823434740.USD","BK4608","BK4137","EB","LU0353189763.USD","LU2272731782.SGD","VSTS","LU1923623000.USD","BK4607","BK4588","LU1951198990.SGD","LU0353189680.USD","LU0823434583.USD",".IXIC","ABTC","BK4200","BK4023","LU0154245673.USD","BK4108","LU1861220033.SGD","BK4613","LU2357305700.SGD","LU1548497426.USD","LU1951200564.SGD","LU1720051017.SGD","LU1992135399.USD","BK4116","BK4139","SIG","BK4077","LU0082616367.USD","LU0390134368.USD","BK4585","LU1720051108.HKD","LU2272731600.USD","BK4539","LU1992135472.HKD"],"gpt_icon":1},{"id":"2588051902","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:43 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2588051902","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588051902?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:43","pubTimestamp":1764686583,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:43 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nAQN2LBQ6N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2588053510","title":"Polyrizon Achieves Key Manufacturing Milestone for Nasal Spray Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2588053510","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588053510?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:55","pubTimestamp":1764680110,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has announced the successful completion of a major manufacturing upscaling milestone for its proprietary nasal-spray product platform, based on its Capture & Contain (C&C) technology. The company, in collaboration with its CDMO partner, successfully transitioned from small-batch laboratory production to a larger-scale manufacturing run, validating the ability to produce its PL-14 intranasal protective spray at higher volumes while maintaining quality standards. PL-14 is designed to create a fast-acting, moisturizing barrier in the nasal cavity to trap and neutralize airborne allergens. The upscaled manufacturing process will support the production of clinical trial material, with clinical trials expected to begin in 2026. The results of this milestone were announced and have not yet been presented in a scientific forum.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL67m5mx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","PLRZ","LU0314104364.USD","BK4585","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","NDAQ","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112"],"gpt_icon":0},{"id":"2586945752","title":"Polyrizon Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2586945752","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586945752?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:50","pubTimestamp":1764204627,"startTime":"0","endTime":"0","summary":"19:50 EST Polyrizon (PLRZ) Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2586291092","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2586291092","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586291092?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:50","pubTimestamp":1764204600,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nAQN2LB6DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2586471633","title":"Why Is Polyrizon Stock (PLRZ) Down Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2586471633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586471633?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:34","pubTimestamp":1764081284,"startTime":"0","endTime":"0","summary":"Polyrizon stock fell hard after the company announced a reverse stock split for later this week.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-polyrizon-stock-plrz-down-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-polyrizon-stock-plrz-down-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2586047347","title":"Polyrizon: Announces That It Will Effect a Reverse Share Split of Co's Ordinary Shares at the Ratio of 1-for-6 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586047347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586047347?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:03","pubTimestamp":1764075810,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polyrizon-biotech.com","stockEarnings":[{"period":"1week","weight":0.0697},{"period":"1month","weight":1.586},{"period":"3month","weight":0.7748},{"period":"6month","weight":1.5983},{"period":"1year","weight":-0.992},{"period":"ytd","weight":-0.9964}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Polyrizon Ltd.","nameEN":"Polyrizon Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Polyrizon Ltd.(PLRZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Polyrizon Ltd.(PLRZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Polyrizon Ltd.,PLRZ,Polyrizon Ltd.股票,Polyrizon Ltd.股票老虎,Polyrizon Ltd.股票老虎国际,Polyrizon Ltd.行情,Polyrizon Ltd.股票行情,Polyrizon Ltd.股价,Polyrizon Ltd.股市,Polyrizon Ltd.股票价格,Polyrizon Ltd.股票交易,Polyrizon Ltd.股票购买,Polyrizon Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Polyrizon Ltd.(PLRZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Polyrizon Ltd.(PLRZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}